Perspective Therapeutics (CATX) Intangibles (2011 - 2026)

Perspective Therapeutics (CATX) reported Intangibles of $40.0 million for Q1 2026, down 20.0% on a YoY basis from $50.0 million in Q1 2025, and little changed sequentially from $40.0 million in Q4 2025.

Perspective Therapeutics (CATX) Intangibles (2011 - 2026) Analysis & Trends

Perspective Therapeutics (CATX) has 8 years of Intangibles data on file, last reported at $40.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Intangibles fell 20.0% year-over-year to $40.0 million; the trailing twelve-month figure through Mar 2026 stood at $40.0 million (down 20.0% YoY), and the FY2025 full-year result was $40.0 million, down 20.0% from the prior year.
  • Intangibles steadied at $40.0 million in Q1 2026, from $40.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $50.0 million in Q1 2023 to a low of $40.0 million in Q4 2025.
  • A 4-year average of $48.5 million and a median of $50.0 million in 2023 frame the typical range for Intangibles.
  • Across the five-year window, Intangibles changed 0.0% in 2024 and decreased 20.0% in 2025, its largest moves.
  • Tracing CATX's Intangibles over 4 years: stood at $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024, then fell by 20.0% to $40.0 million in 2025, then changed by 0.0% to $40.0 million in 2026.
  • Business Quant data shows CATX's Intangibles at $40.0 million in Q1 2026, $40.0 million in Q4 2025, and $50.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.88 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 5.52 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 10.15 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 7.06 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 1.23 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 62.60 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.14 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 1.91 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 882.00 Mn
10 Perspective Therapeutics 146.05 Mn 146.05 Mn - 40.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.00 Mn
Dec 31, 2025 40.00 Mn
Sep 30, 2025 50.00 Mn
Jun 30, 2025 50.00 Mn
Mar 31, 2025 50.00 Mn
Dec 31, 2024 50.00 Mn
Sep 30, 2024 50.00 Mn
Jun 30, 2024 50.00 Mn
Mar 31, 2024 50.00 Mn
Dec 31, 2023 50.00 Mn
Sep 30, 2023 50.00 Mn
Jun 30, 2023 50.00 Mn
Mar 31, 2023 50.00 Mn
Jun 30, 2015 198,490.00
Jun 30, 2014 223,756.00
Jun 30, 2012 203,256.00
Jun 30, 2011 203,194.00